Relação entre estresse e habilidades sociais em docentes do ensino superior do estado da Bahia / Relationship between stress and social skills in professors in the state of Bahia / Relación entre estrés y habilidades sociales en los docentes universitarios del estado de Bahía

Este estudo pretendeu caracterizar o estresse e as habilidades sociais de docentes do ensino superior do Estado da Bahia. Ao lado disso, buscou verificar a relação existente entre esses construtos. Para tanto, aplicou o Inventário de Sintomas de Stress para Adultos de Lipp e o Inventário de Habilidades Sociais (IHS) em 152 docentes do ensino superior de instituições públicas e privadas da Bahia. Os participantes se dedicavam a diferentes áreas e, em sua maioria, pertenciam ao gênero masculino. Trinta e cinco docentes apresentaram quadros característicos das fases de resistência e quase-exaustão. Ao lado disso, evidenciou-se que os sintomas físicos foram os mais presentes, assim como um baixo repertório de habilidades sociais em "autocontrole da agressividade" e "enfrentamento e autoafirmação com risco". Não houve diferenças significativas em habilidades sociais entre os docentes com sintomatologia de estresse e os sem sintomatologia. Dada a relevância da temática e suas implicações, ressalta-se a necessidade de novas investigações.

This study sought to characterize the stress and social skills of professors in higher education in the state of Bahia. We attempted to verify the relationship between these constructs. To do so, it has been applied the Symptoms of Stress Inventory by Lipp and Social Skills Inventory (HSI) in 152 professors in higher education public and private institutions of Bahia. Participants were engaged in different areas and, in most cases, were male. Thirty-five professors showed characteristic frames phases of resistance and near-exhaustion. In addition, it became clear that the physical symptoms were more present, as well as low social skills in "Self-Control Aggression" and "Coping with risk and self-assertion". There were no significant differences in social skills among Professors with symptoms of stress and Professors without symptoms. Given the relevance of this topic and its implications, it is worth highlighting the need for further investigations.

Este estudio trata de caracterizar el estrés y las habilidades sociales de los docentes de la educación superior en el estado de Bahía. Junto a esto, se intentó verificar la relación entre estos constructos. Para ello, se aplicó el Inventario de Síntomas de Estrés para Adultos de Lipp y el Inventario de Habilidades Sociales (IHS) en 152 docentes de las instituciones públicas y privadas de educación superior de Bahía. Los participantes se dedicaban a diferentes áreas y, en la mayoría de los casos, pertenecían al género masculino. Treinta y cinco docentes mostraron marcos característicos de las fases de resistencia y agotamiento casi total. Junto a esto, se hizo evidente que los síntomas físicos fueron los más presentes, así como un bajo repertorio de habilidades sociales en "autocontrol de la agresividad" y "enfrentamiento y autoafirmación con riesgo". No hubo diferencias significativas en habilidades sociales entre los docentes con síntomas de estrés y los que no tenían esos síntomas. Dada la relevancia de este tema y sus implicaciones, se destaca la necesidad de nuevas investigaciones.

Nutritonal evaluation of pemphigus foliaceus patients on long term glucocorticoid therapy.

Our objective was to compare food intake and nutritional status of Pemphigus Foliaceus patients (PG) on long term glucocorticoid therapy to a Control Group (CG). Fourteen PG female inpatients receiving prednisone (0.33 +/- 0.22mg/kg) for at least 12 months and twelve CG subjects were submitted to nutritional evaluation, including anthropometry, urinary creatinine determination and serum biochemical measurements, besides 48-h-based food intake records. Groups were compared by Chi-square, Mann-Whitney and "t" tests. PG patients and CG were paired, respectively, in relation to age (24.7 +/- 14.1 vs. 22.0 +/- 12.0 years), body mass index (25.8 +/- 6.4 vs. 24.0 +/- 5.6kg/m2), daily protein intake (132.9 +/- 49.8 vs. 95.2 +/- 58.9g), and serum albumin (median; range) (3.8; 3.5-4.1 vs. 3.8; 3.6-5.0g/dl). However, PG patients had lower height-creatinine index (64.8 +/- 17.6 vs. 90.1 +/- 33.4%), and higher daily energy (3080 +/- 1099 vs. 2187 +/- 702kcal) and carbohydrate (376.8 +/- 135.8 vs. 242.0 +/- 80.7g) intakes. Despite high food, protein and energy consumption, PG patients on long term glucocorticoid therapy had lower body muscle mass than controls, while showing high body fat stores. These findings are possibly related to combined metabolic effects of long term corticotherapy and inflammatory disease plus corticosteroid-induced increased appetite.

Comparative persistent efficacy of doramectin, ivermectin and fenbendazole against natural nematode infections in cattle.

A study was conducted in Argentina, to investigate the period of protection of a single injection of doramectin administered subcutaneously (s.c.) at 200 micrograms kg-1 (1 ml/50 kg) compared with single treatments of ivermectin (200 micrograms kg-1 s.c.) and fenbendazole (5 mg kg-1 p.o.), against field infections of gastrointestinal parasites of cattle. Eighty-three animals were selected and ranked on the basis of serial fecal egg counts (e.p.g.'s). From this group, three animals were slaughtered before treatment and their lungs, abomasum, small and large intestines, were processed for parasite counts and identification. The remaining 80 animals were allocated in ranked groups of four to a control or one of three treated groups. Animals of the four groups were grazed together in the same pasture for the duration of the study. Treatments were administered on Day 0. Individual fecal samples were collected at weekly intervals for the first 49 days post-treatment and twice a week from Day 52 to Day 84 (end of study). At each collection day fecal samples were pooled for coprocultures. On Day 28 and 56, two animals from each group, previously identified on Day 0, were killed and their parasite burdens determined. The duration of protection of a single injection of doramectin was longer than ivermectin or fenbendazole treatment. On Day 56, the total number of parasites found in doramectin-treated animals was significantly (P < 0.05) lower than parasite burdens found in either ivermectin- or fenbendazole-treated animals. The longer persistent activity of doramectin was expressed by the lower number of adults and L4 stages of Ostertagia ostertagi. Data from this experiment demonstrated the limitations of using fecal egg counts to evaluate the persistent efficacy of anthelmintics. The duration of activity of doramectin was demonstrated more accurately by parasite counts in cattle from each group since decreasing e.p.g.'s were seen in non-medicated animals without changes in total parasite burdens.

Protective efficacy of doramectin and ivermectin against Cochliomyia hominivorax.

Two studies were conducted in Brazil using induced infestations of the New World screwworm, Cochliomyia hominivorax, to investigate: a) the comparative prophylactic efficacy of doramectin and ivermectin at their recommended use levels (200 micrograms kg-1 s.c.), and b) the duration of protection of a single injection of doramectin. In the comparative efficacy study, two groups of six animals each were treated with ivermectin or doramectin. Two hours after treatment, four incisions were made. Each incision was infested with 30 first instar C. hominivorax larvae and their status evaluated daily for 7 days post-treatment (p.t.). Doramectin treatment was 100% effective in prevention of C. hominivorax infestations whereas ivermectin efficacy was incomplete. First instar larvae were eliminated in doramectin-treated calves by 48 h p.t., while in the ivermectin group, C. hominivorax developed in over 29% of the incisions. Healing began in wounds of doramectin-treated animals at 24 h p.t. and was in progress in 100% of all wounds at 2 days p.t., while 50% of ivermectin-treated calves showed incisions with active lesions. In the duration of protection study, 24 calves were allocated to six groups (T1-T6) of four animals each. Three groups (T1, T3 and T5) were treated with saline and three groups (T2, T4 and T6) with doramectin. Animals were infested as described previously according to the following schedule: T1 and T2 at day 14, T3 and T4 at day 21, and T5 and T6 at day 28 p.t. Incisions were evaluated daily for 8 days post-infestation. Screwworm infestations and viable third-instar larvae developed of all incisions of saline-treated calves, while doramectin was 100% effective preventing development of C. hominivorax for 21 days p.t. and showed partial activity at 28 days p.t.

Efficacy of injectable doramectin in the therapy and control of Dermatobia hominis infestations in Latin America.

Three studies were conducted in Latin America, one in Brazil, one in Venezuela and one in Argentina, using a common protocol to investigate the efficacy of a single subcutaneous injection of doramectin at 200 micrograms kg-1 (1 ml per 50 kg) for the treatment and control of Dermatobia hominis infestations in cattle raised under commercial conditions. In each study, two groups of 20 animals each were allocated on the basis of D. hominis nodules present 24 h before treatment to a treated group (T1), or to a control group (T2) which received saline solution at 1 ml per 50 kg of live weight. All cattle were injected in the mid-dorsal cervical region and examined on treatment day and 2, 7, 15 and 30 days post-treatment (p.t.). At each observation day the number of D. hominis nodules was counted and the viability of the larvae inside them was assessed and recorded. Treatment with doramectin was 100% effective in eliminating D. hominis larvae and in controlling the re-establishment of the parasite under field conditions of continuous reinfestation. During the first 48 h p.t., dead larvae of different ages were found outside or partially outside the nodules in animals of the doramectin groups. After 48 h p.t., no live larvae were found inside existing nodules, nor did new nodules develop in animals of the doramectin groups in any of the three studies. When compared with nodule counts in the control group on the same observation day or with parasite burdens on the same animal before treatment, doramectin-treated animals began to eliminate parasitic nodules at 48 h p.t. Efficacy reached 100% at 7 days p.t. and remained at 100% on subsequent observation days (P < 0.05). None of the doramectin-treated animals exhibited any clinical signs of adverse reaction to medication.

Efficacy of injectable doramectin in the protection of castrated cattle against field infestations of Cochliomyia hominivorax.

Three studies were conducted in Latin America--one in Venezuela, one in Argentina and one in Brazil--using a common protocol to investigate the efficacy of a single subcutaneous injection of doramectin in the prevention and control of Cochliomyia hominivorax infestations in castrated cattle. In each study, two groups of 20-28 animals each were allocated to a treated (T1) or to a control (T2) group on the basis of body weights. Animals of T1 received doramectin at 200 micrograms kg-1 (1 ml per 50 kg) and animals of T2 received saline solution at 1 ml per 50 kg of live weight. After treatment all cattle were castrated surgically. Animals were examined on treatment day and at 2, 4, 6 and 12 days post-treatment. At each observation day, the presence of C. hominivorax infestations was recorded. Doramectin was 100% effective in the prevention and control of screwworm strikes in castrated cattle exposed to continuous field infestations of C. hominivorax in tropical and subtropical areas of Latin America. Over the 12 day duration of the studies, 85%, 60% and 65% of animals in the control groups had infested wounds in Venezuela, Argentina and Brazil, respectively. Affected animals required repeated therapeutic treatment, whereas none of the doramectin-treated cattle were infested (P < 0.0001). A high proportion of the castration wounds in doramectin-treated cattle had the presence of characteristic C. hominivorax eggs but none developed into larvae. There were no clinical signs of adverse reactions to treatment in any of the three studies.

Efficacy of doramectin in the protection of neonatal calves and post-parturient cows against field strikes of Cochliomyia hominivorax.

Two studies were conducted in Latin America, one in Venezuela and one in Argentina, using a common protocol to investigate the efficacy of a single s.c. injection of doramectin in the prevention and control of field infestations of Cochliomyia hominivorax in newborn calves and post-parturient cows. In both experiments, pregnant cows were paired on the basis of their calving time. The first cow that calved was assigned to a medicated group, and both cow and calf were treated with doramectin. The cow received a dose of 200 micrograms kg-1 and the calf 1 ml of a 1% doramectin solution. The second cow and calf were assigned to a saline-treated group, and the cow received saline at 1 ml per 50 kg and the calf 1 ml. The procedure was repeated until all animals were allocated to the two treatments. Animals were examined on the treatment day and at 2, 4, 6 and 12 days post-treatment. At each observation day, the navel of newborn calves and external genitalia of the cows were inspected and the presence of C. hominivorax infestations was recorded. Doramectin was 100% effective in the prevention and control of screwworm strikes in newborn calves and in post-parturient cows exposed to continuous field challenge of C. hominivorax. Over the 12 day duration of the studies, 48% and 57% of the saline-treated calves had screwworm navel strikes in the studies in Venezuela and Argentina, respectively. Infested animals required repeated therapeutic treatment, whereas none of the doramectin-treated calves were affected (P < 0.005).(ABSTRACT TRUNCATED AT 250 WORDS)

Efficacy of injectable doramectin against natural Boophilus microplus infestations in cattle.

Three experiments were conducted in Latin America--1 in Brazil, 1 in Venezuela, and 1 in Argentina--using a common protocol to investigate the efficacy of a single SC injection of doramectin (200 micrograms/kg of body weight) for treatment and control of Boophilus microplus infestations in grazing cattle. In each experiment, 2 groups of 20 to 27 cattle were allocated on the basis of tick burdens present 24 hours before treatment to a treated or control group, which received saline solution (1 ml/50 kg). All cattle were injected in the mid-dorsal cervical region and examined on treatment day and on posttreatment days (PTD) 8, 14, 21, and 28. On each observation day, the number of engorged and semiengorged ticks on half of each animals was counted and recorded. Doramectin was highly efficacious in removing tick burdens and controlling reestablishment of B microplus under field conditions of continuous reinfestation. Compared with tick counts in the control group, doramectin-treated cattle began to eliminate ticks after treatment and efficacy improved on subsequent observation days. In Brazil, efficacy was 91% at PTD 8 and 14, and increased to 99% or higher at PTD 21 and 28. In Venezuela, efficacy was 100% at PTD 8, 14, and 21 and 92% at PTD 28. In Argentina, efficacy progressed from 94.5% at PTD 8 to 99 and 98.5% at PTD 21 and 28, respectively. The reduction of the number of ticks in the doramectin-treated cattle was significant (P < 0.05) at each observation day.(ABSTRACT TRUNCATED AT 250 WORDS)

Therapeutic and persistent efficacy of doramectin against Boophilus microplus in cattle.

One therapeutic and one persistent efficacy study were conducted in Brazil to evaluate doramectin at a dose rate of 200 micrograms kg-1 against induced infestations of the single host tick, Boophilus microplus. Doramectin was highly effective in eliminating established tick populations from cattle and also in preventing infestation by the parasite. In the therapeutic study, 12 calves were infested three times a week along the dorsal line with 2500 recently hatched larvae, for a total of 11 times before treatment. Animals were allocated to two groups on the basis of uniformity of established engorged tick burdens. Six calves were treated with doramectin and six received saline solution. From Day -3 to Day 21 post-treatment, individual collections of detached engorged female ticks were made from each calf. In the persistent efficacy study, 12 calves were allocated to two groups of six animals. Six calves were treated with doramectin and six received saline solution. From Day 1 to Day 17 post-treatment, each animal was infested three times a week along the dorsal line with 2500 recently hatched Boophilus microplus larvae, for a total of nine times. From Day 18 to Day 42 post-treatment, daily collections of detached engorged female ticks were made from individual animals. In the therapeutic study, efficacy (reduction of collected engorged female ticks) progressed from 51% at 24 h post-treatment (p.t.) to at least 99% at 4 days p.t., and reached 100% at 8 days p.t. With the exception of one tick that did not lay eggs, recovered from one animal at 11 days p.t., no more ticks were recovered from doramectin-treated calves for the duration of the experiment. For the first 6 days after treatment, only a few detached engorged ticks were collected from treated animals, and their oviposition and hatchability declined rapidly. In the persistent efficacy study, doramectin treatment was highly efficacious in preventing the establishment of Boophilus microplus populations for 20 days after the first ticks completed their cycle in the non-treated group. The oviposition and hatchability of the few ticks that completed their life cycle in the doramectin group were severely reduced.

Efficacy of doramectin against field nematode infections of cattle in Latin America.

Two studies were conducted, one in Argentina and one in Brazil, to evaluate the therapeutic efficacy of doramectin administered subcutaneously at a dose rate of 200 micrograms kg-1 (1 ml per 50 kg) to cattle harboring mixed field infections of gastrointestinal nematodes. In each trial, 20 heifers were randomly allocated to a control or treated group of ten animals each, on the basis of fecal egg counts. Animals in the treated and control groups received an injection of doramectin or saline in the lateral midline of the neck. From 14 to 18 days post-treatment an equal number of animals from each group were slaughtered every day and the worm burdens of doramectin-treated animals were compared with those of non-treated controls. The efficacy of doramectin was at least 99.9% against adult stages of Ostertagia ostertagi, Haemonchus placei, Haemonchus contortus, Haemonchus similis, Trichostrongylus axei, Cooperia pectinata, Cooperia spatulata, Cooperia surnabada (Cooperia mcmasteri), Oesophagostomum radiatum and Dictyocaulus viviparus. Efficacy against Nematodirus helvetianus was 97.9% while efficacy against Trichuris discolor was 92.3%. Activity against inhibited larval forms of Ostertagia ostertagi, H. placei, Oesophagostomum radiatum, and Trichostrongylus axei, was at least 99.9%.

Therapeutic and persistent efficacy of doramectin against Dermatobia hominis in cattle.

One therapeutic and one persistent efficacy study were conducted in Brazil to evaluate doramectin at a dose rate of 200 micrograms/kg-1 against induced infestations of the tropical warble-fly, Dermatobia hominis. Doramectin was very effective in both the treatment of established infestations and also in the prevention of damage caused by the parasite. In the therapeutic trial, 12 calves were infested along the dorsal line with 25 first instar larvae of recent field isolates of D. hominis but in one calf nodules did not develop. Twenty-four days later animals were allocated to two groups on the basis of the number of parasite nodules present. Six calves were treated with doramectin, and five received saline solution. Animals were examined daily for 11 days post-treatment and the number of nodules mapped and recorded. Larvae that completed development were collected and incubated to evaluate viability. In the persistent efficacy study, 24 calves were allocated to six groups (T1-T6) of four animals each. On the day of treatment, three groups (T1, T3 and T5) were treated with saline and three groups (T2, T4 and T6) with doramectin. At 21 days, 28 days and 35 days post-treatment, 25 first instar D. hominis larvae were seeded along the dorsal line of each calf of T1 and T2, T3 and T4, and T5 and T6, respectively. Animals were examined daily for 18 days and the number of nodules mapped and recorded 6, 12 and 18 days post-infestation.(ABSTRACT TRUNCATED AT 250 WORDS)

Prophylactic and persistent efficacy of doramectin against Cochliomyia hominivorax in cattle.

Two prophylactic studies and one persistent efficacy study were conducted in Brazil to evaluate one injection of doramectin at a dose rate of 200 micrograms kg-1 against induced infestations of the New World screwworm, Cochliomyia hominivorax. In each prophylactic study, 12 calves were allocated to two groups of six animals. Six calves were treated with doramectin and six with saline. Two hours after treatment, animals were anesthetized and received two incisions, one in the shoulder and one in the rump. Each incision was then infested with 50 first instar larvae. In the persistent efficacy study, 24 calves were allocated to six groups (T1-T6) of four animals each. On the day of treatment, three groups (T1, T3 and T5) were treated with saline and three groups (T2, T4 and T6) with doramectin. All animals were anesthetized and received four incisions, one in the shoulder and one in the rump of each side. Each incision was then infested with 30 first instar larvae of C. hominivorax with the following schedule: T1 and T2 at Day 3, T3 and T4 at Day 7, and T5 and T6 at Day 14 post-treatment. Calves were observed daily and incisions evaluated for 8 days post-infection. Larvae that completed development and exited the wounds were collected and incubated to evaluate viability. In all experiments, doramectin was 100% efficacious in preventing screwworm infestation caused by field isolates of C. hominivorax. First instar larvae were eliminated from the incisions of doramectin-treated calves between 24 and 48 h post-treatment, and no third instar were recovered at any time. As a consequence, healing started at 24 h and was completed at 96-120 h post-infection. Screwworm infestations and viable third-instar larvae developed in all the incisions in non-treated calves, and healing did not begin until larvae had completed their normal life cycle and exited the wounds. The persistent efficacy of a single injection of doramectin extended beyond 14 days.